0001209191-19-057557.txt : 20191121
0001209191-19-057557.hdr.sgml : 20191121
20191121085910
ACCESSION NUMBER: 0001209191-19-057557
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191118
FILED AS OF DATE: 20191121
DATE AS OF CHANGE: 20191121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tardio Jason
CENTRAL INDEX KEY: 0001794698
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38085
FILM NUMBER: 191235853
MAIL ADDRESS:
STREET 1: 1460 BROADWAY
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ovid Therapeutics Inc.
CENTRAL INDEX KEY: 0001636651
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465270895
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1460 BROADWAY
STREET 2: SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 212-776-4381
MAIL ADDRESS:
STREET 1: 1460 BROADWAY
STREET 2: SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-11-18
0
0001636651
Ovid Therapeutics Inc.
OVID
0001794698
Tardio Jason
C/O OVID THERAPEUTICS INC.
1460 BROADWAY, SUITE 15044
NEW YORK
NY
10036
0
1
0
0
Chief Commercial Officer
Stock Option (Right to Buy)
2.76
2019-11-18
4
A
0
125000
0.00
A
2029-11-17
Common Stock
125000
125000
D
25% of the shares subject to the Stock Option will vest and become exercisable on November 18, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.
/s/ Danielle Mann for Jason Tardio by PoA
2019-11-21